NEWS

• Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America

  Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships, a global initiative designed to support women and minority-group students pursuing careers in science, technology, engineering, and mathematics (STEM). The program includes dedicated intakes in Australia and the broader Asia-Pacific region, as well as North America, reinforcing the company’s commitment to equity and inclusion in clinical research.

• Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials

  Lindus Health and Quotient Sciences partnership combines Quotient's specialized early clinical and drug development capabilities with Lindus’ proven patient recruitment expertise and later-stage trial delivery.

• Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience
• Yoncare s.r.o. Partners With Block Clinical Inc. To Deliver EU-Centric Clinical Trial Participant Travel And Payment Services In Europe
• Block Clinical Discusses Patient Travel Support With Panel Members
• Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development

  Under the new agreement, Quotient Sciences will have access to Intrepid’s machine learning model, ANDROMEDA, the first AI platform to develop and optimize clinical performance of drug products. The platform is designed to significantly reduce formulation development timelines, reduce API demands and increase formulation understanding, helping clients reach critical milestones faster and improve confidence in clinical success.

• One App To Simplify The Clinical Trial Journey

  Unified mobile app streamlines trial tasks—scheduling, questionnaires, travel, and reimbursements—reducing burden and improving engagement for patients and study teams.

• Avance Clinical Showcases Early Phase Expertise And The Australian Advantage For EU Biotechs At BIO-Europe Vienna

  Avance Clinical, the largest premium full-service Australian headquartered CRO with more than 30 years of early phase expertise, is highlighting its Early Phase Center of Excellence for Biotechs and the well-established Australian Advantage to European biotechs ahead of BIO-Europe in Vienna, November 3-5, 2025.

• Meet Avance Clinical At SCOPE Summit 2026 In Orlando, Florida

  Avance Clinical is excited to announce our participation in SCOPE Summit 2026, one of the most influential gatherings in clinical operations, where leading innovators in biotech, pharma, CROs, and technology come together to share strategies shaping the future of global drug development.

• Signant Health Appoints Internationally Recognized Cognitive Assessment Expert John Harrison To Further Advance Innovation In CNS Clinical Trials

  Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of John Harrison as Clinical Vice President

• Avance Clinical Launches Renal And Cardiometabolic Center Of Excellence To Optimize Patient Recruitment To Elevate Study Success

  Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence.

• Avance Clinical Unveils Dedicated CNS Center Of Excellence For Expert Clinical Trial Services In Neuroscience

  Avance Clinical, the award-winning Australian-led, global CRO built exclusively to service the clinical research needs of biotech companies, today announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders.

• Suvoda Expands EU Patient Travel with Bolt Partnership

  New partnership offers EU clinical trial patients reliable, no-cost transportation, reducing travel burdens, improving retention, and supporting access across diverse populations.

• Avance Clinical Launches Dedicated Center Of Excellence To Accelerate Early Phase Biotech Trials